ASX:ACR Acrux (ACR) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free ACR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield11.66%Price TargetN/A Stock AnalysisStock Analysis Get Acrux alerts: Email Address Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here About Acrux Stock (ASX:ACR)Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.Read More Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here ACR Stock News HeadlinesMarch 26, 2024 | msn.comDanner Mountain Light II review: a sturdy classic for modern hikersFebruary 5, 2024 | ca.style.yahoo.com6 best winter boots for Canadian winters — how to stay warm in 5°C to -50°CMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.January 29, 2024 | msn.comHot Money Monday: How momentum investors can exploit overconfidence and skepticism in the marketJanuary 21, 2024 | foxnews.comGoogle engineer found 'spattered in blood' following alleged murder of wife in upscale California home: policeDecember 13, 2023 | bizjournals.comTaste of Belgium reveals brand revitalization with new University Heights Bistro locationDecember 7, 2023 | msn.comRoad repairs to look out for in San Diego this monthDecember 3, 2023 | msn.comHot Money Monday: Momentum trading has been a popular strategy for decades, and here’s how you can use itMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. November 29, 2023 | msn.comAdidas Terrex Free Hiker GTX Hiking Shoes 2.0 review: boots with bounceNovember 24, 2023 | msn.comThe 10 Best Hiking Boots for Men to Wear on Any Outdoor AdventureNovember 22, 2023 | finance.yahoo.comAcrux Limited's (ASX:ACR) CEO Will Probably Find It Hard To See A Huge Raise This YearNovember 21, 2023 | msn.comStreet Resurfacing Planned in Clairemont, Mira Mesa, Torrey Hills, La Jolla and University CityNovember 21, 2023 | msn.comSome San Diego streets are getting a holiday makeover. Here’s whereNovember 17, 2023 | yahoo.comThe Weekly Covet: The Best Boots for Fall & Winter, According to T&C EditorsNovember 6, 2023 | msn.comThe 81 Best Gifts for Outdoorsmen, Tested and Reviewed by an Adventure EnthusiastNovember 3, 2023 | yahoo.comThe 15 Best Men's Hiking Boots for Any Kind of TerrainOctober 25, 2023 | msn.com13 best women’s hiking boots for rambling and trekkingOctober 20, 2023 | msn.comThe 80 Best Gifts for Outdoorsmen, Tested and Reviewed by an Adventure EnthusiastSeptember 9, 2023 | msn.comSalomon Elixir Mid Gore-Tex Boots review: Chunky hooves with a rock-and-roll soleAugust 13, 2023 | thetimes.co.uk‘Poker star’s’ luxury yacht sunk by fireAugust 13, 2023 | mirror.co.ukFormentera superyacht bursts into flames as passengers escape for their livesAugust 8, 2023 | msn.comCovid variant Eris that is spreading in the UK now was detected in India in MayJuly 17, 2023 | ca.style.yahoo.com16 best hiking boots & shoes for women in 2023 | lululemon, Merrell, Columbia & moreJuly 16, 2023 | msn.comCovid-19 positivity rate dips to 5.6 percentJuly 4, 2023 | finance.yahoo.comTestosterone Replacement Therapy Global Market Report 2023May 17, 2023 | marketwatch.comTargeted Drug Delivery System Market 2023 Global Analysis, Size, Share, Industry Overview, Demand, Growth and Forecast 2029See More Headlines Receive ACR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acrux and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/21/2019Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:ACR CUSIPN/A CIKN/A Webwww.acrux.com.au Phone+61-3-83790100FaxN/AEmployees2,018Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,660,000.00 Net Margins-6.21% Pretax MarginN/A Return on Equity-12.21% Return on Assets-15.12% Debt Debt-to-Equity Ratio40.07 Current Ratio2.09 Quick Ratio2.89 Sales & Book Value Annual Sales$11.42 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.57 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares290,720,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.24 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Michael John Kotsanis B.Sc. (Age 58)BSc, GradDipBus, MBus, CEO, MD & Executive Director Comp: $517.86kMs. Joanna Johnson B.E.BEc, ICAA, CFO & Company SecretaryKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersRoss DobinsonSold 418,851 sharesTotal: $23,036.81 ($0.06/share)Timothy OldhamBought 414,561 shares on 12/20/2023Total: $18,655.25 ($0.05/share)Geoffrey BrookeSold 1,062,946 sharesTotal: $52,084.35 ($0.05/share)Ross DobinsonSold 237,610 sharesTotal: $10,217.23 ($0.04/share)Ross DobinsonBought 237,610 shares on 8/30/2023Total: $11,405.28 ($0.05/share) ACR Stock Analysis - Frequently Asked Questions How were Acrux's earnings last quarter? Acrux Limited (ASX:ACR) released its quarterly earnings results on Thursday, February, 21st. The company reported ($0.02) EPS for the quarter. Acrux had a negative net margin of 6.21% and a negative trailing twelve-month return on equity of 12.21%. Is Acrux a good dividend stock? Acrux (ASX:ACR) pays an annual dividend of A$0.09 per share and currently has a dividend yield of 11.66%. ACR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What other stocks do shareholders of Acrux own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acrux investors own include ANZ Group (ANZ), Lynas Rare Earths (LYC), Altium (ALU), Atlas Iron (AGO), Hugo Boss (BOSS), BHP Group (BHP), Beacon Roofing Supply (BECN), Billabong International (BBG), Abraxas Petroleum (AXAS) and Ausdrill (ASL). This page (ASX:ACR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrux Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.